MoneyWorks4Me

The revenue zoomed 11.70% to Rs. 9523.10 millions for the quarter ended June 2024 as compared to Rs. 8525.80 millions during the corresponding quarter last year.Profit saw a slight increase of 19.82%to Rs. 1732.30  millions from Rs. 1445.70 millions.OP of the company witnessed a marginal growth to 2785.40 millions from 2399.60 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 9523.10 8525.80 11.70 9523.10 8525.80 11.70 32986.40 28841.60 14.37
Other Income 51.60 51.30 0.58 51.60 51.30 0.58 346.80 86.50 300.92
PBIDT 2785.40 2399.60 16.08 2785.40 2399.60 16.08 9141.00 6733.40 35.76
Interest 43.20 112.10 -61.46 43.20 112.10 -61.46 405.20 343.10 18.10
PBDT 2742.20 2287.50 19.88 2742.20 2287.50 19.88 8735.80 6390.30 36.70
Depreciation 400.10 306.50 30.54 400.10 306.50 30.54 1352.40 1119.90 20.76
PBT 2342.10 1981.00 18.23 2342.10 1981.00 18.23 7383.40 5270.40 40.09
TAX 609.80 535.30 13.92 609.80 535.30 13.92 1949.80 1381.50 41.14
Deferred Tax 83.70 133.00 -37.07 83.70 133.00 -37.07 494.90 548.00 -9.69
PAT 1732.30 1445.70 19.82 1732.30 1445.70 19.82 5433.60 3888.90 39.72
Equity 155.20 154.80 0.26 155.20 154.80 0.26 155.20 154.80 0.26
PBIDTM(%) 29.25 28.15 3.92 29.25 28.15 3.92 27.71 23.35 18.70
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..